Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Colonoscopy Reduces Colorectal Cancer Risk, But Only on the Left Side

By HospiMedica International staff writers
Posted on 12 Jan 2010
A new study of colonoscopy screening in the community setting shows that it does reduce the risk for colorectal cancer, but only for left-sided, not right-sided, cancers.

Researchers at the German Cancer Research Center (DKFZ; Heidelberg) and other institutions conducted a cross-sectional study involving 3,287 participants from the German state of Saarland aged 55 years or older who underwent screening colonoscopy between May 1, 2005, and December 31, 2007. More...
Prevalence of advanced colorectal neoplasms was ascertained by screening colonoscopy and histopathologic examination of any polyps excised. Previous colonoscopy history was obtained by standardized questionnaire, and its association with prevalence of advanced colorectal neoplasms was estimated after adjustment for potential confounding factors.

The results showed that advanced colorectal neoplasms were detected in 308 (11.4%) of the 2,701 participants with no previous colonoscopy, compared with 36 (6.1%) of the 586 participants who had undergone colonoscopy within the preceding 10 years. After adjustment, the results showed that the prevalence ratios for previous colonoscopy in the previous 10-year period were 0.52 overall; 0.99 in the cecum and ascending colon; 1.21 in the hepatic flexure and transverse colon; and 1.05 in the combined right-sided colon (cecum to transverse colon). In the splenic flexure and descending colon, the prevalence ratio was 0.36; 0.29 in the sigmoid colon; 0.07 in the rectum; and 0.33 in the combined left colon (splenic flexure to rectum). The researchers concluded that the prevalence of left-sided advanced colorectal neoplasms, but not right-sided advanced neoplasms, was strongly reduced within a 10-year period after colonoscopy, even in the community setting. The study was published online on December 30, 2009, in the Journal of the National Cancer Institute.

"Although a strong protective effect of colonoscopy from colorectal neoplasms has been established through previous studies, our results add to the evidence that this effect is much stronger in, if not confined to, the left colon and rectum--at least in the community setting,” said lead author Hermann Brenner, M.D, M.P.H, of the DKFZ.

Colonoscopy is the endoscopic examination of the colon and the distal part of the small bowel with a video or fiberoptic camera on a flexible tube passed through the anus. It may provide a visual diagnosis of ulceration and polyps, and grants the opportunity for biopsy and removal of suspected lesions.

Related Links:

German Cancer Research Center



Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Fetal Monitor
BT-380
Gold Member
Blood Gas Analyzer
i-Check200
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.